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Cell lines were derived from mice with murine gammaherpesvirus-68 (MHV-68)-associated lymphoprolif-
erative disease. Four were of an ambiguous phenotype and were MHV-68 negative. One, S11, was a B
lymphocyte that contained MHV-68 genomes in both linear and episomal forms and released virus. The line
was clonable and grew into tumors in nude mice. This is the first naturally occurring MHV-68-positive B-cell
line to be generated, and it will be an invaluable tool for the study of MHV-68 latency.
Murine gammaherpesvirus-68 (MHV-68) provides an amen-
able small-animal model for the study of gammaherpesvirus
pathogenesis. MHV-68 establishes a latent infection in B lym-
phocytes following an acute respiratory infection (1a, 14–16).
Previous results from this laboratory have shown that at late
times after infection (.6 months) some 10% of mice devel-
oped lymphoproliferative disease and after treatment with cy-
closplorin A the proportion rose to 60%. A high proportion
(50%) of affected mice displayed high-grade lymphomas (13).
These lymphomas were usually associated with the spleen or
mesenteric lymph nodes; however, lung, liver, and kidney tis-
sues were also affected.
In terms of cellular transformation the most thoroughly
studied gammaherpesviruses are Epstein-Barr virus (EBV)
and herpesvirus saimiri. Cell lines derived from EBV-, herpes-
virus saimiri-, and herpesvirus ateles-induced tumors have
been extremely useful in the study of virus latency and the
discovery of virus genes responsible for cellular transforma-
tion.
This paper reports the derivation of five cell lines from
MHV-68-infected mice with lymphoproliferative disease, one
of which was infected with MHV-68. The nature of the infec-
tion in this cell line was investigated and was found to be very
similar to that reported for other gammaherpesvirus-trans-
formed cell lines.
Derivation and phenotype of lymphoma cell lines. Lines
were generated from BALB/c mice which had been infected
with MHV-68 for .1 year and showed evidence of lymphoma
development in the spleen and/or lymph nodes. Tumor cells
were purified by centrifugation over Histopaque-1077 (Sigma-
Aldrich) initially cultured at a density of 23 106 cells per ml in
RPMI medium plus 10% fetal calf serum. When lines began to
grow, they were passaged at 1 3 105 to 2 3 105 cells per ml.
Lines BLN, SPL, and MLN were derived from mice which
were treated with 1 mg of cyclosporin A (a gift from D. White,
Addenbrookes Hospital, Cambridge, United Kingdom) in ol-
ive oil on days 3, 7, 14, 21, and 28 following infection. BLN and
SPL were from the basal lymph node and spleen of one animal,
and MLN was from the mesenteric lymph node of a second
animal. Lines S11 and S31 were both derived from spleen cell
cultures, with S31 coming from a thymectomized CD8-de-
pleted mouse treated with the antiherpesvirus compound 29-
deoxy-5-ethyl-beta-49-thiouridine (C9) (9). This compound has
been shown to be highly effective in inhibiting MHV-68 repli-
cation (1).
Each line was stained with a panel of monoclonal antibodies
specific for lymphocyte surface markers, and the presence of
these markers was measured by cytofluorimetric analysis using
a FACScan device (Becton Dickinson) as described previously
(17). All antibodies—except biotinylated anti-immunoglobulin
M (IgM) (Sera-lab, Sussex, United Kingdom); biotinylated
(Fab9)2 anti-mouse Ig and fluorescein isothiocyanate-conju-
gated anti-rabbit Ig (Dako Ltd., High Wycombe, United King-
dom); fluorescein isothiocyanate-conjugated anti-rat Ig (Sero-
tec, Oxford, United Kingdom); and anti-CD3 and anti-CD5,
which were hybridoma supernatants from the lines KT3-1.1
and YTS121.5.2, respectively (gifts from S. Cobbold, Univer-
sity of Oxford)—and fluorescein isothiocyanate-conjugated
streptavidin were purchased from Pharmingen (San Diego,
Calif.). All lines expressed major histocompatibility complex
class I MHC-I and intercellular adhesion molecule 1
(ICAM-1) (Table 1), whereas none expressed CD3, a marker
restricted to T lymphocytes. Line S11 also expressed IgM on
the cell surface, in addition to major histocompatibility com-
plex class II and a very low level of the B-cell-specific marker
B220. Line S31 expressed a very low level of B220 but was
negative for surface IgM, and lines MLN, SPL, and BLN were
negative for all other surface markers. The presence of intra-
cellular Ig was also tested by immunocytochemistry; the only
positive line was S11. Thus, S11 was of the B-lymphocyte lin-
eage, whereas the phenotypes of the other lines remained
ambiguous. Lines MLN, BLN, and SPL grew as a layer of
adherent single lymphoblastoid-type cells; S11 cells had a sim-
ilar morphology but grew in small clumps of approximately 10
to 12 cells with some adherent cells, a few of which sent out
elongated processes. S31 cells were similar in size to resting
lymphocytes and grew in large balls.
Cytogenetic analysis of the lines. Lines BLN, MLN, SPL,
and S11 had multiple chromosomal duplications and translo-
cations. Line S31 contained 41 to 42 chromosomes in compar-
ison with the normal diploid complement of 40 chromosomes.
Presence of MHV-68 in tumor cell lines. High-molecular-
weight DNA was prepared from each cell line and used as a
substrate for PCRs with primers specific for the MHV-68
gp150 gene as described previously (12). This analysis showed
that S11 was the only line carrying the MHV-68 genome. This
line was investigated in greater detail. The PCR was made
* Corresponding author. Mailing address: Department of Veteri-
nary Pathology, The University of Edinburgh, Summerhall, Edinburgh
EH9 1QH, United Kingdom. Phone: 44 131 650 6159. Fax: 44 131 650
6511. Electronic mail address: Edward.Usherwood@ed.ac.uk.
6516
quantitative by the use of a competitive template that con-
tained the same primer binding sites but was different in size.
Such a mutant competitor template was made by first cloning
the 480-bp gp150 PCR product into the vector pUC19. A
100-bp fragment was then deleted from the insert by cutting
plasmid DNA with AvaI, religating, and recloning. This gen-
erated a plasmid with an insert which contained the binding
sites for the gp150 primers but which, when amplified, gave a
product which was 100 bp smaller than that produced by am-
plification of viral DNA. A series of PCRs were then per-
formed with the same amount of S11 DNA but spiked with a
dilution series of defined quantities of mutant competitor tem-
plate. The relative amounts of mutant competitor and target
sequence were analyzed by densitometry, and the amount of
S11 DNA present was calculated by construction of a standard
curve exactly as described previously (6, 10). By using this
technique on DNA derived from S11 cells which had been
treated for 2 weeks with C9 to eliminate traces of DNA asso-
ciated with productive replication, it was established that, on
average, each cell contained 40 copies of the virus genome.
A proportion of S11 cells produced virus particles, as cocul-
tivation with permissive BHK cells (14) produced infective
centers which stained positive with anti-MHV-68 rabbit hyper-
immune serum. The line became more lytic with passage in
vitro; 2 to 4% of the cells gave rise to infective centers after 12
weeks in culture, with the level rising to 6 to 7% after 5 months
and 20 to 30% after 9 months. Free virus was detectable in the
culture supernatant and in cell lysates.
To determine whether it was possible to increase the num-
ber of lytically infected cells in the culture, replicate cultures
were treated with either 20 ng of phorbol 12-myristate 13-
acetate (TPA) per ml dissolved in dimethyl sulfoxide or an
equal volume of dimethyl sulfoxide alone and incubated for
48 h. Immunofluorescent staining of cell smears with rabbit
hyperimmune anti-MHV-68 serum revealed that 3.2% of the
control cells were positive for virus antigen compared with
10.4% of the TPA-treated cells. Thus, in a fashion analogous to
that observed with EBV (19), TPA could reactivate otherwise
latently infected cells within the culture.
The integrity of the virus genome in the S11 line was tested
by preparing virion DNA from productively infected BHK cells
and comparing this DNA with that of the parental strain (g2.4)
by restriction enzyme analysis using the enzymes BamHI,
EcoRI, and HindIII. This analysis revealed no observable de-
letions in S11 virus relative to the parental strain, in contrast to
deletions reported for other gammaherpesviruses isolated
from latently infected lines (7).
Antiherpesvirus drug treatment of the S11 line. To deter-
mine the effect of antiherpesvirus drug treatment on the
MHV-68-infected S11 line, cells were cultured in the presence
of 1 mg of C9 per ml. At 4 or 19 days posttreatment cells were
cocultivated with BHK cells for 5 days and the number of
infective centers was enumerated. Cell lysates, obtained by
three cycles of freeze-thaw in liquid nitrogen, were also cocul-
tivated to determine the level of free (i.e., nonlatent) cell-
associated virus. The results are shown in Fig. 1. C9 treatment
reduced the level of free virus to undetectable levels, whereas
the cells remained latently infected as evidenced by the fact
that 5 to 6% reactivated to give rise to infective centers. After
withdrawal of the drug, free virus was again detectable.
Latent infection in the S11 line. Studies with related gam-
maherpesviruses have shown that viral genomes are in a linear
form during productive replication but an episomal form dur-
ing latency. To determine the state of the virus genome in the
S11 line, cells were subjected to electrophoresis according to
the method of Gardella et al. (5), which resolves episomal and
linear genomes. A blot of the gel was probed with a 32P-
labelled probe specific for the MHV-68 gL homolog as de-
scribed previously (11), and the relative proportions of linear
and episomal DNA were estimated by using Quantiscan den-
sitometric software (Biosoft, Cambridge, United Kingdom). As
shown in Fig. 2, the S11 line contained both episomal and
linear forms of the MHV-68 genome, in a ratio of 1:3.0. Pre-
treatment of the S11 cells with 100 mM acyclovir for 48 h
resulted in an increase in the ratio of circular genomes to linear
genomes to 1:2.3. Conversely, pretreatment with 20 ng of TPA
per ml decreased the circular-to-linear ratio to 1:11.6, consis-
tent with reactivation of latent virus from the line.
We were concerned that the S11 line may have been a
carrier culture in which only a proportion of the cells were
infected. To address this question, the line was washed to
remove free virus and then cloned by limiting dilution at 0.3 or
1 cell per well. Eleven clones, all of which were positive for
virus genomes by PCR, were derived in this way, demonstrat-
ing that all cells in the culture were MHV-68 infected.
Growth of the S11 line in nude mice. Two groups of six
BALB/c nude mice received either 106 or 107 S11 cells subcu-
taneously in the lower left flank and were observed over a
period of 1 month for tumor development. For the mice re-
ceiving 107 cells, three of six developed solid tumors in situ,
FIG. 1. Numbers of infective centers and free (i.e., nonlatent) virus PFU
after treatment of the S11 line with C9. †, cells were cultured in the presence of
1 mg of C9 per ml for 15 days, and then the drug was withdrawn for 4 days.
TABLE 1. Phenotypes of tumor cell lines
a
Antigen
Fluorescence intensity (arbitrary units) in:
S11 S31 BLN MLN SPL
CD3 1 0 0 0 2
IgM 26 0 0 0 0
Intracellular Igb 1 2 2 2 2
B220 (CD45R) 6 6 2 1 3
CD5 1 1 0 1 1
MHC-I 39 50 35 25 32
MHC-II 39 43 8 0 5
ICAM-1 21 54 36 36 39
MHV-68c 1 2 2 2 2
a Surface antigen expression was measured by flow cytometry. Values shown
are mean fluorescence intensities after subtraction of background fluorescence
(second-step reagent alone).
b 1, positive staining by immunofluorescence; 2, no staining observed.
c 1, DNA samples positive by PCR; 2, DNA samples negative by PCR.
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compared with one of six for the group receiving 106 cells.
Subcutaneous injection of S11 cells into euthymic BALB/c
mice did not result in tumor development.
This report represents the first study of a naturally infected
B-cell line explanted from an MHV-68-infected mouse.
MHV-68 behaved in a way similar to that of other gammaher-
pesviruses during a latent infection in the S11 line, the genome
persisted in an episomal form, and the culture could not be
cured with an antiherpesvirus drug. When injected into athy-
mic nude mice, S11 cells gave rise to tumors, and it was pos-
sible to grow clones from single cells of the S11 line. These last
two properties suggest that the line is more reminiscent of
Burkitt’s lymphoma cells than it is of lymphoblastoid cell lines
derived from in vitro infection (8), although the S11 cells did
have an activated phenotype and grew as clumps.
Only one of five cell lines from MHV-68-infected mice car-
ried the virus genome. This may indicate a role for the virus in
tumor initiation, but it does not appear to be necessary for
continued tumor cell growth. This would not be unusual, as
EBV-related Burkitt’s lymphoma is believed to require other
cofactors, such as malaria infection, for tumor development (2,
3, 18).
This reagent should prove invaluable in the hunt for virus
genes expressed during latent infection and also as a target cell
for virus-specific cytotoxic T lymphocytes. In addition it may
provide information on transformation processes used by hu-
man gammaherpesviruses such as the newly discovered human
herpesvirus 8 (4) and EBV.
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FIG. 2. Gardella gel analysis of cell lines and MHV-68. Cells (2 3 106) or
MHV-68 virions (100 ml of stock at 107 PFU/ml) were loaded into the wells of a
horizontal Gardella agarose gel, electrophoresed, and blotted, and blots were
probed with an MHV-68 gL homolog probe. S11 tumor cells were loaded either
without treatment or after treatment with acyclovir (ACV) or TPA for 48 h as
indicated above the tracks. The relative positions of linear and circular virion
DNA are indicated on the left.
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